ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress
Go back to ORYZON Presents Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia (AML) at European Hematology Association (EHA) 2026 Annual Congress| ORION MARINE GROUP, Inc. (NYSE: ORN) | Delayed: 15.60 -0.29 (1.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.89 | 52 Week High | $9.48 | |||
| Open | $15.90 | 52 Week Low | $3.25 | |||
| Day High | $16.21 | P/E | N/A | |||
| Day Low | $15.55 | EPS | $-0.01 | |||
| Volume | 552,192 | |||||
